Exploring the challenges for pricing and reimbursement of high-cost combination therapies

Gain market access insight from payer and pricing experts from across the EU into:

• the reimbursement mechanisms for combination products
• the access challenges these mechanisms present for new innovative combinations
• the scope for potential solutions
• the policy direction in France, Germany, and the UK